Prehľad nových klinických štúdií
Účinnosť LA-5™ a BB-12™ je overená desiatkami klinických štúdií.
Prehľad niektorých najnovších klinických štúdií, publikovaných od roku 2005 do februára 2007 na www.pubmed.com:
- Boyle, R. J., R. M. Robins-Browne, et al. (2006). "Probiotic use in clinical practice: what are the risks?" Am J Clin Nutr 83(6): 1256-64; quiz 1446-7.
- Collado, M. C., L. Jalonen, et al. (2006). "Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus." Asia Pac J Clin Nutr 15(4): 570-5.
- Hutt, P., J. Shchepetova, et al. (2006). "Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens." J Appl Microbiol 100(6): 1324-32.
- Laake, K. O., A. Bjorneklett, et al. (2005). "Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis." Scand J Gastroenterol 40(1): 43-51.
- Larsen, C. N., S. Nielsen, et al. (2006). "Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults." Eur J Clin Nutr.
- Lesniewska, V., I. Rowland, et al. (2006). "Effect on components of the intestinal microflora and plasma neuropeptide levels of feeding Lactobacillus delbrueckii, Bifidobacterium lactis, and inulin to adult and elderly rats." Appl Environ Microbiol 72(10): 6533-8.
- Mohan, R., C. Koebnick, et al. (2006). "Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study." J Clin Microbiol 44(11): 4025-31.
- Rafter, J., M. Bennett, et al. (2007). "Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients." Am J Clin Nutr 85(2): 488-96.
- Ruiz, P. A., M. Hoffmann, et al. (2005). "Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats." Immunology 115(4): 441-50.
- Saarela, M., J. Maukonen, et al. (2007). "Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention." Int J Antimicrob Agents 29(3): 271-80.
- Salminen, S., Y. Benno, et al. (2006). "Intestinal colonisation, microbiota and future probiotics?" Asia Pac J Clin Nutr 15(4): 558-62.
- Trushina, E. N., O. K. Mustafina, et al. (2006). "[The immune-enhancing effects of oral administration of strains bifidobacteria in experiments]." Vopr Pitan 75(5): 70-4.
- Vernazza, C. L., G. R. Gibson, et al. (2006). "Carbohydrate preference, acid tolerance and bile tolerance in five strains of Bifidobacterium." J Appl Microbiol 100(4): 846-53.
- Wildt, S., L. K. Munck, et al. (2006). "Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis." Inflamm Bowel Dis 12(5): 395-401.
